Mary Kay Fenton

Chief Financial Officer at Cullinan Therapeutics · 3 reported transactions in 1 company · latest trade Feb 20, 2026

Their trades


Cullinan TherapeuticsCGEM	Sold $59.9K · 4,398 shares	Feb 20, 2026	S&P 500 +9.6%thru Oct 30

Feb 20, 2026 · CGEM

$59.9K

S&P 500 +9.6%thru Oct 30

3 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Chief Financial Officer at Cullinan Therapeutics · 3 reported transactions in 1 company · latest trade Feb 20, 2026


Cullinan TherapeuticsCGEM	Sold $59.9K · 4,398 shares	Feb 20, 2026	S&P 500 +9.6%thru Oct 30

Feb 20, 2026 · CGEM

$59.9K

S&P 500 +9.6%thru Oct 30

3 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.